Tuberculosis is still a major health problem in some parts of the world, even if it isn’t nearly the health issue in the United States that it was years ago.
Dr. Tawanda Gumbo, director of the Center for Infectious Diseases Research and Experimental Therapeutics at the Baylor Scott & White Research Institute, is leading a research initiative aimed at testing the effectiveness of medications given to those afflicted with the disease, D Healthcare Daily reported.
Tuberculosis is still present in as much as 3 percent of some countries’ populations, particularly in places such as India, China, and South America, D Healthcare Daily said.
Gumbo’s research recently was published in the Clinical Infectious Diseases journal. It included details of a model for testing medicines on pediatric TB patients.
D Healthcare reported that that genesis of Gumbo’s research dates back to his medical training in the African nation of Zimbabwe, where he realized that what he was reading in the books about the effectiveness of tuberculosis treatments weren’t reflected by what he was seeing in the people he studied.
He realized something wasn’t right. The books were old, and the disease had morphed, D Healthcare said. Some strains responded to antibiotics, while others did not.
You can find out more about Gumbo, his research, and how he came to Baylor Scott & White here at D Healthcare Daily.
Delivering what’s new and next in Dallas-Fort Worth innovation, every day. Get the Dallas Innovates e-newsletter.
R E A D N E X T
-
In this weekly roundup of executive moves in North Texas, you'll also find news from Operation Kindness, Cooksey Communications, Munck Wilson Mandala, and StoneEagle F&I.
-
In partnership with the Southwestern Medical Foundation, the Cary Council awarded $50K grants to each of its three 2021 young "DocStars." On a recent "What's Up Doc?" virtual event, the young investigators spoke about how their research projects are going, what they hope to achieve—and why the seed grants are a catalyst for medical innovation.
-
BALANCED Media | Technology has won the second annual Grand Challenge competition for its edge computing solution. Gamers downloaded a small game. While they played, they were also processing data to help find COVID-fighting compounds. Its HEWMEN crowd-computing platform
-
Alpha Testing, geotechnical engineering firm, will retain and expand its local presence with the deal. Its leadership team will also stay on to launch a new "Texas division" for Universal Engineering Sciences’ national offerings. Alpha Testing's major North Texas projects include Fort Worth’s West 7th Bridge, DFW Airport, the Cypress Waters mixed-use development, and more.
-
Ellie Diagnostics, named for its founder's furry friend, wants to put wellness at the forefront of animal health. The startup offers diagnostic solutions to veterinarians that it says are more accessible to pet owners.
